TABLE 3.
Power calculation for the MR analysis in current study.
Exposure |
Outcome |
OR | Proportion of variance explained by the SNPs on exposure | Power | |||
Trait | Sample size | Trait | Sample size | Proportion of cases | |||
T2D | 659,316 | Hip OA | 382,833 | 0.0336 | 1.1708 | 0.0508 | 99% |
T2D | 659,316 | Knee OA | 391,904 | 0.0559 | 0.9046 | 0.0508 | 87% |
FG | 133,010 | Hip OA | 382,833 | 0.0336 | 0.4634 | 0.0029 | 91% |
FG | 133,010 | Knee OA | 391,904 | 0.0559 | 0.5890 | 0.0029 | 91% |
2hGlu | 42,854 | Hip OA | 382,833 | 0.0336 | 1.3062 | 0.0074 | 83% |
2hGlu | 42,854 | Knee OA | 391,904 | 0.0559 | 1.3652 | 0.0074 | 99% |
T2D, type 2 diabetes; FG, fasting glucose; 2hGlu, 2-h postprandial glucose; OA, osteoarthritis; OR, odds ratio; SNP, single nucleotide polymorphism.